GSK STOCKMANN

Dr Timo Patrick Bernau is a partner at our Munich office and heads our Banking and Finance division. He has extensive expertise in advising banks, financial service providers, fintechs, insurance companies and insurtechs, with a particular focus on regulatory issues, investment products and capital market compliance.
In addition, he provides comprehensive guidance on alternative investments, restructuring and structured financing. Timo has extensive knowledge of current banking and finance issues, including AIFMD II and ELTIFs, MiCAR, DORA, the AI Act, tokenisation and stable coins, securitisation and alternative assets as well as FiDA. He is frequently featured in high-profile industry rankings and regularly publishes on banking and finance topics.

Andreas Heinzmann is a partner within the capital markets and banking group in the Luxembourg office of GSK Stockmann. He specialises in securities law, capital markets regulation and international banking work. Andreas Heinzmann advises clients on the issue of debt and equity securities (including stock exchange listings), securitisations, high yield bonds, repackagings, structured products and derivatives as well as syndicated lending, leveraged finance and debt restructuring. He publishes regularly in this field of expertise.

Dr. Martin Freytag is an associate at GSK Stockmann in Munich. He specializes advising banks, financial service providers, investment fund managers and institutional investors on financial and insurance regulatory issues; setting-up and structuring of financial instruments such as investment funds, securitisations, bonds, structured finance and mezzanine financing; capital market and stock exchange law as well as advising on electronic payment services. He is admitted to the Bar in Germany (2022) and speaks German, English and French. He is a member of the Bankrechtliche Vereinigung – Wissenschaftliche Gesellschaft für Bankrecht e.V. and publishes regularly.